Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
Tomazou M, Bourdakou MM, Minadakis G, Zachariou M, Oulas A, Karatzas E, Loizidou EM, Kakouri AC, Christodoulou CC, Savva K, Zanti M, Onisiforou A, Afxenti S, Richter J, Christodoulou CG, Kyprianou T, Kolios G, Dietis N, Spyrou GM.
Tomazou M, et al. Among authors: karatzas e.
Brief Bioinform. 2021 Nov 5;22(6):bbab114. doi: 10.1093/bib/bbab114.
Brief Bioinform. 2021.
PMID: 34009288
Free PMC article.